Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage (Q36349732)

13 August 2017

1 reference

title

Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage (English)

1 reference

13 August 2017

Mehmet Akif Topcuoglu

series ordinal

1

1 reference

PubMed ID

16370956

13 August 2017

Aneesh B Singhal

series ordinal

2

1 reference

PubMed ID

16370956

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

Expert Opinion on Drug Safety

13 August 2017

1 reference

13 August 2017

5

1 reference

13 August 2017

1

1 reference

13 August 2017

57-65

1 reference

Cerebral Vasospasm Following Subarachnoid Hemorrhage

13 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Surgical risk as related to time of intervention in the repair of intracranial aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Molecular keys to the problems of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Signal transduction pathways in cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Vascular smooth muscle function: The physiology and pathology of vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Role of p38 mitogen-activated protein kinase on cerebral vasospasm after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Protein kinase C and cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Signaling mechanisms in cerebral vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Effects of a 20-HETE antagonist and agonists on cerebral vascular tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

SAH-induced cerebral vasospasm: unraveling molecular mechanisms of a complex disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

High-dose methylprednisolone prevents vasospasm after subarachnoid hemorrhage through inhibition of protein kinase C activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Antihypertensive drugs: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

21 January 2018

Calcium-antagonist drugs

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Reversible cardiogenic shock complicating subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Role of calcium and protein kinase C in the activation of phospholipase D by angiotensin II in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Impact of the renin-angiotensin system on cerebral perfusion following subarachnoid haemorrhage in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Has plasma renin activity a prognostic significance in subarachnoid haemorrhage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Impairment of anti-platelet-aggregating activity of endothelial cells after experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Discontinuing chronic aspirin therapy: another risk factor for stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Cerebral vasoconstriction and stroke after use of serotonergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Receptor changes in cerebral arteries after subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Cocaine use is an independent risk factor for cerebral vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Alpha-adrenoreceptors and muscarine receptors in human pial arteries and microvessels: a receptor binding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Effects of statins on endothelium and signaling mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Withdrawal of statins increases event rates in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Intravenous nitroglycerin in experimental cerebral vasospasm. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

Transdermal nitroglycerin in patients with subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.57

21 January 2018

Identifiers

DOI

10.1517/14740338.5.1.57

1 reference

13 August 2017

1 reference

PubMed ID

16370956